Monica Messina

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

EJHaem

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alfonso Piciocchi, Marta Cipriani, Monica Messina, Giovanni Marconi, Valentina Arena, Stefano Soddu, Enrico Crea, Maria Valeria Feraco, Marco Ferrante, Edoardo La Sala, Paola Fazi, Francesco Buccisano, Maria Teresa Voso, Giovanni Martinelli, Adriano Venditti, Marco Vignetti
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients. EJHaem 5 (2) (2024)
Alfonso Piciocchi, Marta Cipriani, Monica Messina, Giovanni Marconi, Valentina Arena, Stefano Soddu, Enrico Crea, Maria Valeria Feraco, Marco Ferrante, Edoardo La Sala, Paola Fazi, Francesco Buccisano, Maria Teresa Voso, Giovanni Martinelli, Adriano Venditti, Marco Vignetti
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients. EJHaem 5 (2) (2024)
Alfonso Piciocchi, Marta Cipriani, Monica Messina, Giovanni Marconi, Valentina Arena, Stefano Soddu, Enrico Crea, Maria Valeria Feraco, Marco Ferrante, Edoardo La Sala, Paola Fazi, Francesco Buccisano, Maria Teresa Voso, Giovanni Martinelli, Adriano Venditti, Marco Vignetti
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients. EJHaem 5 (2) (2024)
Giovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, Walter Barberi, Laura Santodonato, Giuseppina D'Agostino, Elisabetta Abruzzese, Maria Ilaria Del Principe, Alessandra Mancino, Mabel Matarazzo, Mahnaz Shafii Bafti, Marco Mancini, Monica Messina, Luciano Castiello, Anna Guarini, Robin Foà
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial. American journal of hematology 97 (6) (2022)
Alfonso Piciocchi, Monica Messina, Stefano Soddu, Edoardo La Sala, Francesca Paoloni, Giorgia Giuliani, Martina R Marino, Claudia Petrelli, Livia Gorreo Renzulli, Paola Fazi, Marco Vignetti
The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges. British journal of haematology 190 (4) (2020)

Monica Messina.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Monica Messina